Internal Medicine · Flint, MI
NPI
1023493574
Since 2015
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
401 S Ballenger Hwy
Flint, MI, 48532
Phone (810) 342-2968
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
1,449 services
Medicare patients, 2024
322
Average age 72
Drug cost, 2024
$581K
2,100 prescriptions
Company payments, 2025
$741
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wajdi Al Shweiat was code 99214 (office e&m - established), 458 times for 171 patients. In total Wajdi Al Shweiat billed 1,449 services in 20 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 458 | 171 | $90.81 | $42K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 452 | 171 | $12.61 | $5,699 |
| 90960 ESRD Related Services (not dialysis) | Office | 149 | 63 | $270.87 | $40K |
| 99232 Hospital E&M - Subsequent | Facility | 144 | 68 | $64.42 | $9,277 |
| 90935 Hemodialysis | Facility | 41 | 25 | $58.25 | $2,388 |
| 99233 Hospital E&M - Subsequent | Facility | 40 | 23 | $97.41 | $3,896 |
| 90961 ESRD Related Services (not dialysis) | Office | 34 | 27 | $222.25 | $7,557 |
| 99204 Office E&M - New | Office | 30 | 30 | $130.16 | $3,905 |
| 90966 ESRD Related Services (not dialysis) | Office | 26 | 11 | $227.44 | $5,914 |
| 99222 Hospital E&M - Initial | Facility | 23 | 21 | $107.57 | $2,474 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $142.53 | $1,995 |
By year: 2022 $160K for 1,266 services; 2023 $145K for 1,185 services; 2024 $128K for 1,449 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wajdi Al Shweiat prescribed most often to Medicare patients was Amlodipine Besylate, with 319 prescriptions and refills. In total Wajdi Al Shweiat wrote 2,100 Medicare prescriptions that cost $581K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 319 | 830 | 114 | $2,438 |
| Jardiance Empagliflozin | 206 | 435 | 73 | $249K |
| Olmesartan Medoxomil Generic | 194 | 515 | 72 | $4,135 |
| Lisinopril Generic | 154 | 423 | 56 | $1,244 |
| Torsemide Generic | 143 | 363 | 71 | $3,780 |
| Farxiga Dapagliflozin Propanediol | 88 | 187 | 24 | $102K |
| Doxazosin Mesylate Generic | 72 | 207 | 28 | $1,388 |
| Kerendia Finerenone | 66 | 159 | 24 | $100K |
| Chlorthalidone Generic | 64 | 182 | 26 | $1,161 |
| Furosemide Generic | 53 | 138 | 25 | $436 |
| Losartan Potassium Generic | 52 | 145 | 22 | $506 |
| Carvedilol Generic | 49 | 140 | 28 | $650 |
| Lokelma Sodium Zirconium Cyclosilicate | 38 | 77 | 18 | $52K |
| Potassium Citrate Er Potassium Citrate | 37 | 76 | 12 | $5,061 |
| Sodium Polystyrene Sulfonate Generic | 35 | 62 | 14 | $5,107 |
Brand drugs: 437 claims; generic drugs: 1,663 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wajdi Al Shweiat $741 (- in general payments such as food, travel and fees and $741 for research) from 5 companies. The largest payer was Eli Lilly and Company with $741.
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company LLY | 1 | $741 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.